Clinical Proteomics for Patient Stratification - A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE)

Home > Science Hub > Clinical Proteomics for Patient Stratification - A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE)
Back to the list

July 29, 2020

Maxim Isabelle, Michael Schirm, Gwenaël Pottiez, Rudolf Guilbaud, and Lorella Di Donato

Clinical Proteomics for Patient Stratification – A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE), AACR 2020

Clinical Proteomics for Patient Stratification - A GCLP Quantitative Mass Spectrometry Workflow for Multiplexed Measurement of Protein Biomarkers in FFPE Tissues (FFPE)

Download poster

You might also be interested by

Scientific Publications

Preclinical and clinical biomarker studies of CT1812:
A novel approach to Alzheimer’s disease modification

February 8, 2021

Proteomics/Mass Spectrometry

More info

Posters

Patient Stratification using Clinical Proteomics – Validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues

November 9, 2020

Proteomics/Mass Spectrometry

More info

Posters

Quantification of sBCMA in Human Plasma using a High-Throughput Mass Spectrometry Workflow for Exploratory, CAP/CLIA or Regulated Studies

November 9, 2020

Proteomics/Mass Spectrometry

More info

Insight from our experts

Insight From Our Experts:
Discussing MHC Peptide Analysis with Eustache Paramithiotis

July 13, 2020

Proteomics/Mass Spectrometry

More info